nanog's groups:

Cancer Stem Cell (created by nanog)
Hematopoiesis (created by nanog)

nanog's tags:


Users who used clinical-grade:

EXPORT LIST RSS ?
nanog's bookmarks matching tag clinical-grade
 
Number of articles per page:
10 | 25 | 50 | 100
 
Rapid Large-Scale Expansion of Functional Mesenchymal Stem Cells from Unmanipulated Bone Marrow without Animal Serum.
Katharina Schallmoser et al.
Tissue engineering. Part C, Methods, (11 Jul 2008)
 
Large-Scale Production of Human Adipose Tissue from Stem Cells: A New Tool for Regenerative Medicine and Tissue Banking.
Francesco D'andrea et al.
Tissue engineering. Part A, (01 Jul 2008)
 
Evaluation of 'out-of-specification' CliniMACS CD34-selection procedures of hematopoietic progenitor cell-apheresis products.
E Braakman et al.
Cytotherapy 10 (1), 83-9 (2008)
 
Clinical grade expansion of human bone marrow mesenchymal stem cells.
Panagiota A Sotiropoulou, Sonia A Perez, and Michael Papamichail
Methods in molecular biology (Clifton, N.J.) 407, 245-63 (2007)
 
Clinical grade production of mesenchymal stem cells.
Luc Sensebé
Bio-medical materials and engineering 18 (1 Suppl), S3-10 (2008)
Posted by nanog to clinical-grade expansion MSC on Wed May 07 2008 at 02:03 UTC | info | related
 
Retronectin®-assisted retroviral transduction of primary human T lymphocytes under good manufacturing practice conditions: tissue culture bag critically determines cell yield
 
Investigational new drugs submitted to the Food and Drug Administration that are placed on clinical hold: the experience of the Office of Cellular, Tissue and Gene Therapy
Wonnacott, K.Lavoie, D.McIntyre, M.Huang, Y.Fiorentino, R.Hi S.
Cytotherapy: Articles recently published in, (01 Jan 2008)
 
Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factor.
D Lorenzon et al.
Vox sanguinis, (14 Feb 2008)
 
ISHAGE-based single-platform flowcytometric analysis for measurement of absolute viable T cells in fresh or cryopreserved products: CD34/CD133 selected or CD3/CD19 depleted stem cells, DLI and purified CD56(+)CD3 (-) NK cells.
U Koehl et al.
International journal of hematology 87 (1), 98-105 (Jan 2008)
 
Refreezing of cord blood hematopoietic stem cells for allogenic transplantation: in vitro and in vivo validation of a clinical phase I/II protocol in European and Italian Good Manufacturing Practice conditions.
Monica Gunetti et al.
Exp Hematol 36 (2), 235-43 (Feb 2008)

<< Prev 0      Showing entries 1 to 10 of 28 total      Next 10 >>